University Hospital, Caen
Clinical trials sponsored by University Hospital, Caen, explained in plain language.
-
New hope for elderly myeloma patients: Steroid-Free combo shows promise
Disease control TerminatedThis study tested a combination of two drugs, ixazomib and daratumumab, without using steroids (dexamethasone) in elderly patients (65 and older) whose multiple myeloma had come back after previous treatment. The goal was to see if this approach could effectively control the dise…
Phase: PHASE2 • Sponsor: University Hospital, Caen • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
New combo therapy aims to tame rare artery disease
Disease control TerminatedThis study tested whether adding anakinra (a drug that blocks inflammation) to standard steroid treatment could lower relapse rates in people with giant cell arteritis, a disease that causes swollen arteries. About 30 adults aged 50 and older were enrolled, but the trial was stop…
Phase: PHASE3 • Sponsor: University Hospital, Caen • Aim: Disease control
Last updated May 13, 2026 16:00 UTC